Results 131 to 140 of about 1,413,362 (346)

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Citing the Elite: The Burden of Authorial Anxiety [PDF]

open access: yes, 2007
Academic legal writing is known for extensive citation. Generally, scholars who study citation practices are increasingly likely to link citation with authors\u27 attempts to manage their impression.
Tintle, Shane
core   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Impression [PDF]

open access: yes
‘Impression’ is the written component of the Master of Fine Arts thesis at the University of the Arts Helsinki, Academy of Fine Arts authored by the writer of this text.
Laurinkoski, Ville
core  

Conference Impression [PDF]

open access: yesarXiv, 1999
This paper gives a personal impression of the conference ``Asymmetrical PNe II: From Origins to Microstructures'', flags some of the highlights, gathers together some facts and terminology, and indicates some promising future lines of work in this field.
arxiv  

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy